UP webinar to tackle all COVID-19 drugs, treatment for home and hospital use

| Written by Deina Blancaflor

Two years into the COVID-19 pandemic, there have been great strides in our scientific understanding of the SARS-CoV-2 virus and its variants, paving the way for vaccination as a foundation for prevention. Home-based anti-viral drugs for early treatment are now available. These gradually decreased the risks of hospitalization, severe COVID, and even death.

The World Health Organization (WHO) recently made a strong recommendation for using nirmatrelvir and ritonavir—sold under the name Paxlovid—to treat mild and moderate COVID-19 patients at the highest risk of hospital admission. The WHO describes Paxlovid as the  “best therapeutic choice for high-risk patients.”

Previously, the WHO worked on new data from two randomized controlled trials involving 3,078 patients. The data showed that the risk of hospitalization is reduced by 85% following this treatment. In a high-risk group (over 10% risk of hospitalization), there were 84 fewer hospitalizations per 1,000 patients. 

However, not all countries have access to these drugs. Although available in the Philippines, there is minimal public discussion and proper information dissemination. 

This Friday, May 6, 2022, the University of the Philippines (UP), in partnership with UP Manila National Institutes of Health (UPM-NIH), National Telehealth Center (NTC), and cooperation with UP Philippine General Hospital (UP-PGH), invite you to join the fight against COVID-19.

In this week’s episode of the international award-winning “Stop COVID Deaths” webinar series, two leading experts in COVID-19 management will discuss the current In medicines available both for home and hospital use.

Dr. Franco Felizarta, a US-based infectious disease, and internal medicine specialist, and a member of the UP Medical Alumni Association in America (UPMASA), will discuss nirmatrelvir with ritonavir (Paxlovid) as a drug of choice for home-based care. Dr. Ralph Elvi Villalobos, a consultant with the Division of Pulmonary Medicine from the UP-PGH, will discuss the standard of care for hospitalized patients. Dr. Carmencita D. Padilla, UP Manila Chancellor, will provide the synthesis and deliver the closing remarks.

Register here and catch our weekly live tweets and streams via the UP System Twitter Account, TVUP’s YouTube channel and Facebook page. Join us as we learn about the latest anti-viral drugs and how treatment plays a critical role in controlling the pandemic.

The UP “Stop COVID Deaths” webinar series is the Philippines’ first and only frontline-focused medical webinar series. It pioneered the discussion, dissemination, and adoption of knowledge on COVID-19 treatment and management. Follow our accounts to stay connected with your credible online community.